Cargando…
Combined Administration of Fibrinogen and Factor XIII Concentrate Does Not Improve Dilutional Coagulopathy Superiorly Than Sole Fibrinogen Therapy: Results of an In-Vitro Thrombelastographic Study
The early administration of fibrinogen has gained wide acceptance for the treatment of major hemorrhage, whereas the substitution of coagulation factor XIII (FXIII) is only supported by a low level of evidence. This study aimed to answer the question of whether a combined therapy of fibrinogen/FXIII...
Autores principales: | Schneck, Emmanuel, Muelich, Marcus, Markmann, Melanie, Edinger, Fabian, Cooper, Nina, Moeller, Annette, Bein, Gregor, Hecker, Andreas, Koch, Christian, Sander, Michael, Wolff, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150940/ https://www.ncbi.nlm.nih.gov/pubmed/34065924 http://dx.doi.org/10.3390/jcm10102068 |
Ejemplares similares
-
Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM
por: Winstedt, Dag, et al.
Publicado: (2014) -
Fibrinogen in dilutional coagulopathy: a dose study in pigs
por: Martini, J, et al.
Publicado: (2010) -
Dose-response of fibrinogen and factor XIII concentrate for correcting albumin-induced coagulopathy
por: Schött, US, et al.
Publicado: (2013) -
Importance of fibrinogen in dilutional coagulopathy after neurosurgical procedures: A descriptive study
por: Nair, Shalini, et al.
Publicado: (2016) -
Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
por: Morrow, Gael B., et al.
Publicado: (2021)